| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
An imaging signature to predict outcome in metastatic colorectal cancer using routine computed tomography scans
|
Dercle, Laurent
|
|
|
161 |
C |
p. 138-147
|
artikel
|
| 2 |
Association of tumour burden with the efficacy of programmed cell death-1/programmed cell death ligand-1 inhibitors for treatment-naïve advanced non-small-cell lung cancer
|
Suzuki, Shinichiro
|
|
|
161 |
C |
p. 44-54
|
artikel
|
| 3 |
Bayesian interpretation of immunotherapy trials with dynamic treatment effects
|
Castañon, Eduardo
|
|
|
161 |
C |
p. 79-89
|
artikel
|
| 4 |
Excessive toxicity of cabozantinib in a phase II study in patients with recurrent and/or metastatic salivary gland cancer
|
van Boxtel, Wim
|
|
|
161 |
C |
p. 128-137
|
artikel
|
| 5 |
Extracranial rhabdoid tumours: Results of a SFCE series of patients treated with a dose compression strategy according to European Paediatric Soft tissue sarcoma Study Group recommendations
|
Enault, Maxime
|
|
|
161 |
C |
p. 64-78
|
artikel
|
| 6 |
Global, regional and national burden of primary liver cancer by subtype
|
Rumgay, Harriet
|
|
|
161 |
C |
p. 108-118
|
artikel
|
| 7 |
Impact of COVID-19 and suspension of colorectal cancer screening on incidence and stage distribution of colorectal cancers in the Netherlands
|
Toes-Zoutendijk, Esther
|
|
|
161 |
C |
p. 38-43
|
artikel
|
| 8 |
Primary yolk sac tumour of the liver: A diagnostic pitfall
|
Zhang, Junwei
|
|
|
161 |
C |
p. 23-25
|
artikel
|
| 9 |
Probiotic supplement attenuates chemotherapy-related cognitive impairment in patients with breast cancer: a randomised, double-blind, and placebo-controlled trial
|
Juan, Zhang
|
|
|
161 |
C |
p. 10-22
|
artikel
|
| 10 |
Randomized phase II study of fulvestrant plus palbociclib or placebo in endocrine-sensitive, hormone receptor-positive/HER2–advanced breast cancer: GEICAM/2014–12 (FLIPPER)
|
Albanell, J.
|
|
|
161 |
C |
p. 26-37
|
artikel
|
| 11 |
TERT promoter mutations are associated with longer progression-free and overall survival in patients with BRAF-mutant melanoma receiving BRAF and MEK inhibitor therapy
|
Thielmann, Carl M.
|
|
|
161 |
C |
p. 99-107
|
artikel
|
| 12 |
The impact of pulmonary metastases on therapeutic response and prognosis in malignant gestational trophoblastic neoplasia patients: a retrospective cohort study
|
Jiang, Fang
|
|
|
161 |
C |
p. 119-127
|
artikel
|
| 13 |
The potential of combined shear wave and strain elastography to reduce unnecessary biopsies in breast cancer diagnostics – An international, multicentre trial
|
Golatta, Michael
|
|
|
161 |
C |
p. 1-9
|
artikel
|
| 14 |
Tumour mutational burden predicts resistance to EGFR/BRAF blockade in BRAF-mutated microsatellite stable metastatic colorectal cancer
|
Randon, Giovanni
|
|
|
161 |
C |
p. 90-98
|
artikel
|
| 15 |
Validation of MiROvaR, a microRNA-based predictor of early relapse in early stage epithelial ovarian cancer as a new strategy to optimise patients' prognostic assessment
|
Ditto, Antonino
|
|
|
161 |
C |
p. 55-63
|
artikel
|
Tijdschrift beschrijving